Health Law Daily Wrap Up, FOOD—NOTICES: FDA seeks public input on gluten labeling and cross-contact controls, (Jan 23, 2026)

By WK Editorial Staff

The FDA is seeking public comment on a citizen petition requesting clearer labeling of gluten containing ingredients and stronger controls to prevent gluten cross contact in packaged foods to better protect consumers with celiac disease.

In September 2023, Celiac Journey submitted a citizen petition (Docket No. FDA–2023–P–3942) requesting that FDA act to protect consumers with celiac disease (CD) by better enabling them to identify, through labeling, whether a food includes gluten-containing grains (GCGs), and to address cross-contact with GCGs. The Food and Drug Administration (FDA or we) received a citizen petition from Celiac Journey requesting that we act to protect consumers with celiac disease by requiring that all ingredients with gluten be listed by name in the ingredient list and by requiring cross-contact controls with gluten-containing grains. We are issuing this document to request comment on the issues raised in the petition and on specific questions related to these issues (Notice, 91 Fed. Reg. 2781 (Jan. 22, 2026)).

Dates. Submit either electronic or written comments and scientific data and information by March 23, 2026.

FederalRegisterIssuances: Notices FDCActNews FoodNews FoodStandardsNews